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Sir,
Takebayashi et al (2008) have conducted a case–control study
of 322 cases of brain tumour (glioma, meningioma and pituitary
adenoma) and found no association with mobile phone usage.
There are several flaws in the methodology of their study, which
would lead to a null finding and the risk of a type-2 (false negative)
error.
Cases were recruited from hospitals in the Tokyo area, which, it
was estimated, treat 75% of all brain tumour cases. The
participation rate for the glioma cases was 59%, which was only
43% of the total cases in Tokyo, and slightly higher for the other
tumours. It is remarkable that none of the glioma cases were
reported as having died or were so incapacitated that a proxy (eg, a
spouse) was used for reporting phone usage. This is important
because data from proxies are unreliable.
Exposure data are calculated from interviews using the
Interphone protocol. Information on lifetime history of use of
mobile phone was sought from subjects, including the average
duration and frequency of calls, the make and model of phones
used and the side of the head in contact with the phone. From
these data, cumulative length of use and cumulative call time were
calculated. The authors then combined these data with the
calculated SAR of the various phones to give further measures of
exposure. However, the accuracy of the key data regarding
remembrance of phone usage and call times over past years was
not confirmed from billing data or other sources. The Interphone
study, along with other studies, has found that recall of phone use
even over previous months is inaccurate and may be
associated with random errors, leading to overestimation
or under-estimations of true usage (Parslow et al, 2003;
Samkange-Zeeb et al, 2004; Shum et al, 2005; Vrijheid et al,
2006). It is of concern that the authors do not refer to Interphone’s
own validation study, which highlights this crucial methodological
problem. Using such inaccurate data for estimating cumulative
exposures or for combining with SAR data, will lead to a null
finding.
The controls were selected from the community. They contain
proportionately more subjects who had college education than the
cases (Table 1); education was used as a proxy for socioeconomic
status. The better educated and, therefore, control subjects with
higher socioeconomic status are likely to have been bigger users of
mobile phones because they can better afford them and may be
provided with phones free of cost in the course of their higher
status work. This increased exposure will obscure any effect in the
cases.
It was found that the odds ratio for glioma patients in the most
heavily exposed group was 5.84 (0.96–35.60) (Table 3). The
authors dismiss this finding as recall bias due to persons with a
tumour seeking to attribute it to mobile phone use. However, the
odds ratio for the most exposed meningioma cases was only 1.14
(0.28–4.6). If recall bias is the true explanation for the increased
risk of glioma, it should similarly have affected the meningioma
group, but it has not. Therefore, the increased risk in the glioma
group may be a true finding.
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